TFDP3 inhibits E2F1-induced, p53-mediated apoptosis

Biochemical and Biophysical Research Communications

Volumn 361, Issue 1, 2007, Pages 20-25

  Tian, Chan ^a   Lv, Dan ^a   Qiao, Huan ^a   Zhang, Jun ^a   Yin, Yan hui ^a   Qian, Xiao ping ^a   Wang, Yu ping ^a   Zhang, Yu ^a   Chen, Wei feng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; DP; E2F1; p53; TFDP3

Indexed keywords

PROTEIN; PROTEIN BAX; PROTEIN BID; PROTEIN NOXA; PROTEIN P53; PROTEIN PUMA; PROTEIN TFDP 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL LINE; E2F1 TRANSCRIPTION FACTOR; GAMMA RAYS; HUMANS; TRANSCRIPTION FACTOR DP1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547131831     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.128     Document Type: Article

References (46)

1. Dimova D.K., and Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24 (2005) 2810-2826
2. Tsantoulis P.K., and Gorgoulis V.G. Involvement of E2F transcription factor family in cancer. Eur. J. Cancer 41 (2005) 2403-2414
3. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
4. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3 (2002) 11-20
5. DeGregori J. The genetics and the E2F family of transcription factors: shared function and unique roles. Biochim. Biophys. Acta 1602 (2002) 131-150
6. Bell L.A., and Ryan K.M. Life and death decision by E2F-1. Cell Death Differ. 11 (2004) 137-142
7. Ginsberg D. E2F1 pathways to apoptosis. FEBS Lett. 529 (2002) 122-125
8. Qin X.Q., Livingston D.M., Kaelin Jr. W.G., and Adams P.D. Deregulated E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91 (1994) 10918-10922
9. Shan B., and Lee W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14 (1994) 8166-8173
10. Wu X., and Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91 (1994) 3602-3606
11. Hiebert S.W., Packham G., Strom A.K., Haffner R., Oren M., Zambetti G., and Cleveland J.L. E2F-1: DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15 (1995) 6864-6874
12. Kowalik T.F., DeGregori J., Schwarz J.K., and Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69 (1995) 2491-2500
13. Guy C.T., Zhou W., Kaufman S., and Robinson M.O. E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol. Cell. Biol. 16 (1996) 685-693
14. Holmberg C., Helin K., Sehested M., and Karlstrom O. E2F-1 induced p53-independent apoptosis in transgenic mice. Oncogene 17 (1998) 143-155
15. Pierce A.M., Fisher S.M., Conti C.J., and Johnson D.G. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16 (1998) 1267-1276
16. Pierce A.M., Gimenez-Conti I.B., Schneider-Broussard R., Martinez L.A., Conti C.J., and Jognson D.G. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95 (1998) 8858-8863
17. Pierce A.M., Schneider-Broussard R., Gimenez-Conti I.B., Russell J.L., Conti C.J., and Johnson D.G. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol. Cell. Biol. 19 (1999) 6408-6414
18. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., Orkin S.H., and Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
19. Tsai K.Y., Hu Y., and Macleod K.F. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2 (1998) 293-304
20. Vigo E., Muller H., Prosperini E., Hateboer G., Cartwright P., Moroni M.C., and Helin K. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19 (1999) 6379-6395
21. Denchi E.L., and Helin K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6 (2005) 661-667
22. Ziebold U., Reza T., Caron A., and Lees J.A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15 (2001) 386-391
23. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250
24. Kowalik T.F., DeGregori J., Leone G., Jakoi L., and Nevins J.R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9 (1998) 113-118
25. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., and Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature 395 (1998) 124-125
26. Robertson K.D., and Jones P.A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18 (1998) 6457-6473
27. Rogoff H.A., Pickering M.T., Frame F.M., Debatis M.E., Sanchez Y., Jones S., and Kowalik T.F. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol. Cell. Biol. 24 (2004) 2968-2977
28. Powers J.T., Hong S., Mayhew C.N., Rogers P.M., Knudsen E.S., and Johnson D.G. E2F1 uses the ATM signaling pathway to induce p53 and chk2 phosphorylation and apoptosis. Mol. Cancer Res. 2 (2004) 203-214
29. Hershko T., Chaussepied M., Oren M., and Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ. 12 (2005) 377-383
30. Irwin M., Marin M.C., Phillips A.C., Seelan R.S., Smith D.I., Liu W., Flores E.R., Tsai K.Y., Jacks T., Vousden K.H., and Kaelin Jr. W.G. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407 (2000) 645-648
31. Stiewe T., and Putzer B.M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26 (2000) 464-469
32. Moroni M.C., Hickman E.S., Denchi E.L., Caprara G., Colli E., Cecconi F., Muller H., and Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell. Biol. 3 (2001) 552-558
33. Furukawa Y., Nishimura N., Furukawa Y., Satoh M., Endo H., Iwase S., Yamada H., Matsuda M., Kano Y., and Nakamura M. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 277 (2002) 39760-39868
34. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., Zhang M.Q., Lazebnik Y., Bar-Sagi D., and Lowe S.W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell. Biol. 4 (2002) 859-864
35. Hershko T., and Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J. Biol. Chem. 279 (2004) 8627-8634
36. Di Stefano L., Jensen M.R., and Helin K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 22 (2003) 6289-6298
37. Maiti B., Li J., de Bruin A., Gordon F., Trimmers C., Opavsky R., Patil K., Tuttle J., Cleghorn W., and Leone G. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 280 (2005) 18211-18220
38. Hitchens M.R., and Robbins P.D. The role of the transcription factor DP in apoptosis. Apoptosis 8 (2003) 461-468
39. Milton A., Luoto K., Ingram L., Munro S., Logan N., Graham A.L., Brummelkamp T.R., Hijmans E.M., Bernards R., and La Thangue N.B. A functionally distinct member of the DP family of E2F subunits. Oncogene 25 (2006) 3212-3218
40. Qiao H., Di Stefano L., Tian C., Li Y.Y., Yin Y.H., Qian X.P., Pang X.W., Li Y., McNutt M.A., Helin K., Zhang Y., and Chen W.F. Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F. J. Biol. Chem. 282 (2007) 454-466
41. Hsieh J.K., Fredersdorf S., Kouzarides T., Martin K., and Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11 (1997) 1840-1852
42. Phillips A.C., Bates S., Ryan K.M., Helin K., and Vousden K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11 (1997) 1853-1863
43. Pruschy M., Wirbelauer C., Glanzmann C., Bodis S., and Krek W. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. Cell Growth Differ. 10 (1999) 141-146
44. Nip J., Strom D.K., Fee B.E., Zambetti G., Cleveland J.L., and Hiebert S.W. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17 (1997) 1049-1056
45. Yu J., and Zhang L. The transcriptional atargets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331 (2005) 851-858
46. Willis S.N., and Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell. Biol. 17 (2005) 617-625